BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 32286946)

  • 1. VS-5584 Inhibits Human Osteosarcoma Cells Growth by Induction of G1- phase Arrest through Regulating PI3K/mTOR and MAPK Pathways.
    Sun JY; Hou YJ; Cui HJ; Zhang C; Yang MF; Wang FZ; Sun Z; Fan CD; Sun BL; Oh JR
    Curr Cancer Drug Targets; 2020; 20(8):616-623. PubMed ID: 32286946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piperine inhibits proliferation of human osteosarcoma cells via G2/M phase arrest and metastasis by suppressing MMP-2/-9 expression.
    Zhang J; Zhu X; Li H; Li B; Sun L; Xie T; Zhu T; Zhou H; Ye Z
    Int Immunopharmacol; 2015 Jan; 24(1):50-8. PubMed ID: 25479727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear receptor modulators inhibit osteosarcoma cell proliferation and tumour growth by regulating the mTOR signaling pathway.
    Yuan B; Shi K; Zha J; Cai Y; Gu Y; Huang K; Yue W; Zhai Q; Ding N; Ren W; He W; Xu Y; Wang T
    Cell Death Dis; 2023 Jan; 14(1):51. PubMed ID: 36681687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium cantharidinate suppresses human osteosarcoma MG‑63 cell proliferation and induces cell cycle arrest by inhibition of PI3K/AKT activation.
    Kong DL; Liu Y; Wang JY; Liu G; Zhang ML
    Oncol Rep; 2019 Feb; 41(2):1351-1358. PubMed ID: 30535442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan oligosaccharide suppresses osteosarcoma malignancy by inhibiting CEMIP via the PI3K/AKT/mTOR pathway.
    Sim I; Choe W; Ri J; Su H; Moqbel SAA; Yan W
    Med Oncol; 2023 Sep; 40(10):294. PubMed ID: 37668818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (E)-SIS3 suppressed osteosarcoma progression via promoting cell apoptosis, arresting cell cycle, and regulating the tumor immune microenvironment.
    Huang Z; Zhang C; Zhu K; Hu J; Xu E; Ma X; Wang Y; Zhu Y; Zhu J
    Drug Dev Res; 2023 Dec; 84(8):1751-1763. PubMed ID: 37784254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressing STAT5 signaling affects osteosarcoma growth and stemness.
    Subramaniam D; Angulo P; Ponnurangam S; Dandawate P; Ramamoorthy P; Srinivasan P; Iwakuma T; Weir SJ; Chastain K; Anant S
    Cell Death Dis; 2020 Feb; 11(2):149. PubMed ID: 32094348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sanguinarine induces apoptosis in osteosarcoma by attenuating the binding of STAT3 to the single-stranded DNA-binding protein 1 (SSBP1) promoter region.
    Wang KD; Zhu ML; Qin CJ; Dong RF; Xiao CM; Lin Q; Wei RY; He XY; Zang X; Kong LY; Xia YZ
    Br J Pharmacol; 2023 Dec; 180(24):3175-3193. PubMed ID: 37501645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMNAT1 Is a Survival Factor in Actinomycin D-Induced Osteosarcoma Cell Death.
    Kiss A; Csikos C; Regdon Z; Polgár Z; Virág L; Hegedűs C
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer Effects of Cold Atmospheric Plasma in Canine Osteosarcoma Cells.
    Lee J; Moon H; Ku B; Lee K; Hwang CY; Baek SJ
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of anti‑osteosarcoma activity of asiatic acid based on network pharmacology and
    Pang H; Wu H; Zhan Z; Wu T; Xiang M; Wang Z; Song L; Wei B
    Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium signalling links MYC to NUAK1.
    Monteverde T; Tait-Mulder J; Hedley A; Knight JR; Sansom OJ; Murphy DJ
    Oncogene; 2018 Feb; 37(8):982-992. PubMed ID: 29106388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Targeted Therapies for Osteosarcoma
    Wang S; Ren Q; Li G; Zhao X; Zhao X; Zhang Z
    Curr Mol Pharmacol; 2024; 17(1):e210823220109. PubMed ID: 37602543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix Stiffness Regulated Endoplasmic Reticulum Stress-mediated Apoptosis of Osteosarcoma Cell through Ras Signal Cascades.
    Deng H; Shu X; Wang Y; Zhang J; Yin Y; Wu F; He J
    Cell Biochem Biophys; 2023 Dec; 81(4):839-850. PubMed ID: 37789235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,3,5-triazines inhibit osteosarcoma and avert lung metastasis in a patient-derived orthotopic xenograft mouse model with favorable pharmacokinetics.
    Su Q; Xu B; Tian Z; Gong Z
    Iran J Basic Med Sci; 2022 Mar; 25(3):295-301. PubMed ID: 35656180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the Anticancer Mechanism of OR3 Pigment from Streptomyces coelicolor JUACT03 Against the Human Hepatoma Cell Line Using a Proteomic Approach.
    Derangula S; Nadumane VK
    Cell Biochem Biophys; 2024 Apr; ():. PubMed ID: 38578403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retraction: Cucurbitacin E inhibits osteosarcoma cells proliferation and invasion through attenuation of PI3K/AKT/mTOR signalling pathway.
    Biosci Rep; 2024 Feb; 44(2):. PubMed ID: 38414405
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "CCT128930 induces G1-phase arrest and apoptosis and synergistically enhances the anticancer efficiency of VS5584 in human osteosarcoma cells" [Biomed. Pharmacother. 130 (2020) 110544].
    Sun JY; Hou YJ; Yin YB; Wang FZ; Yang MF; Zhang YY; Fan CD; Sun BL
    Biomed Pharmacother; 2020 Dec; 132():110931. PubMed ID: 33254436
    [No Abstract]   [Full Text] [Related]  

  • 19. CCT128930 induces G1-phase arrest and apoptosis and synergistically enhances the anticancer efficiency of VS5584 in human osteosarcoma cells.
    Sun JY; Hou YJ; Yin YB; Wang FZ; Yang MF; Zhang YY; Fan CD; Sun BL
    Biomed Pharmacother; 2020 Oct; 130():110544. PubMed ID: 32721630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario.
    Candido MF; Medeiros M; Veronez LC; Bastos D; Oliveira KL; Pezuk JA; Valera ET; Brassesco MS
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.